NeutriSci International Inc. (NRXCF) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Cotizando a $, NeutriSci International Inc. (NRXCF) es una empresa del sector Healthcare valorada en 0. La acción obtiene una puntuación de 56/100, una calificación moderada basada en 9 KPI cuantitativos.
Ultimo analisis: 15 mar 2026NeutriSci International Inc. (NRXCF) Resumen de Asistencia Médica y Tuberías
NeutriSci International Inc. operates in the nutraceuticals market, developing and distributing products like neuenergy across North America, Europe, and Asia. With a focus on energy and mental clarity, the company utilizes retail and online channels, facing competition in a fragmented and evolving market landscape.
Tesis de Inversión
Investing in NeutriSci International Inc. presents a high-risk, high-reward scenario. The company's negative gross margin of -9.5% and profit margin of -168.4% raise concerns about its financial sustainability. The company's success hinges on its ability to achieve significant revenue growth and improve its cost structure. Potential catalysts include successful expansion into new markets and the launch of additional nutraceutical products. However, the company's reliance on partnerships and the competitive nature of the nutraceuticals market pose significant risks. The negative beta of -0.83 suggests that the stock moves inversely to the market, which could provide some downside protection during market downturns, but also limit upside potential during bull markets. Investors should closely monitor the company's financial performance and market execution to assess its long-term viability.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- Market Cap of $0.00B indicates a micro-cap company with limited resources and higher volatility.
- P/E Ratio of -1.08 suggests the company is currently unprofitable, making traditional valuation difficult.
- Profit Margin of -168.4% highlights significant challenges in achieving profitability and managing expenses.
- Gross Margin of -9.5% indicates that the cost of goods sold exceeds revenue, raising concerns about pricing and production efficiency.
- Beta of -0.83 suggests the stock has a negative correlation with the market, potentially offering some downside protection during market downturns.
Competidores y Pares
Fortalezas
- Established distribution network in multiple countries.
- Proprietary formulation for neuenergy.
- Partnerships with other companies in the health and wellness industry.
- Focus on a growing market segment (energy and mental clarity).
Debilidades
- Negative gross and profit margins.
- Limited financial resources.
- Dependence on partnerships for distribution.
- Small market capitalization.
Catalizadores
- Upcoming: Potential expansion into new geographic markets, such as Asia and South America, by the end of 2026.
- Upcoming: Launch of new nutraceutical products targeting different health and wellness needs in Q4 2026.
- Ongoing: Strategic partnerships with complementary businesses to expand reach and access new markets.
- Ongoing: Increased online sales through e-commerce platforms and digital marketing initiatives.
- Ongoing: Development of innovative nutraceutical formulations with proprietary ingredients.
Riesgos
- Ongoing: Intense competition in the nutraceuticals market from established brands and emerging players.
- Potential: Changing consumer preferences and regulatory requirements affecting product demand and compliance.
- Potential: Supply chain disruptions impacting the availability and cost of raw materials.
- Potential: Economic downturn affecting consumer spending on discretionary items like nutraceuticals.
- Ongoing: The company's negative gross and profit margins raise concerns about its financial sustainability.
Oportunidades de crecimiento
- Expansion into New Geographies: NeutriSci has the opportunity to expand its distribution network into new geographic markets, particularly in Asia and South America, where demand for nutraceutical products is growing. By establishing partnerships with local distributors and tailoring its product offerings to meet regional preferences, NeutriSci can tap into new revenue streams and diversify its customer base. This expansion could increase revenue by an estimated 20% within the next three years.
- Product Line Diversification: NeutriSci can expand its product line beyond neuenergy to include other nutraceutical products targeting different health and wellness needs. By developing and launching new products in categories such as immune support, digestive health, and sleep enhancement, NeutriSci can attract a broader range of customers and increase its market share. This diversification could lead to a 15% increase in revenue within the next two years.
- Strategic Partnerships: NeutriSci can leverage strategic partnerships with other companies in the health and wellness industry to expand its reach and access new markets. By collaborating with complementary businesses, such as fitness centers, health food stores, and online retailers, NeutriSci can increase its brand awareness and distribution capabilities. These partnerships could contribute to a 10% increase in revenue within the next year.
- Online Sales Growth: NeutriSci can focus on growing its online sales channels through e-commerce platforms and digital marketing initiatives. By investing in search engine optimization (SEO), social media marketing, and targeted advertising, NeutriSci can reach a wider audience and drive online sales. This strategy could result in a 25% increase in online revenue within the next two years.
- Development of Innovative Formulations: NeutriSci can invest in research and development to create innovative nutraceutical formulations that address specific health concerns and provide unique benefits to consumers. By developing proprietary ingredients and delivery systems, NeutriSci can differentiate its products from competitors and attract health-conscious consumers. This innovation could lead to a 20% increase in revenue within the next three years.
Oportunidades
- Expansion into new geographic markets.
- Product line diversification.
- Increased online sales through e-commerce platforms.
- Development of innovative nutraceutical formulations.
Amenazas
- Intense competition in the nutraceuticals market.
- Changing consumer preferences and regulatory requirements.
- Potential supply chain disruptions.
- Economic downturn affecting consumer spending on discretionary items.
Ventajas competitivas
- Proprietary formulations for neuenergy.
- Established distribution network in multiple countries.
- Partnerships with LaSanta Botanicals, Nutritional High, and Naturally Splendid.
- Brand recognition in the energy supplement market.
Acerca de NRXCF
NeutriSci International Inc., established in 2009 and headquartered in Vancouver, Canada, is a nutraceutical company engaged in the development, marketing, and distribution of health and wellness products. The company's flagship product, neuenergy, is an energy tablet designed to enhance focus and mental clarity. NeutriSci distributes its products through a network of retail and online channels, targeting consumers in Canada, the United States, Europe, Asia, and South America. The company has established partnerships with LaSanta Botanicals, Nutritional High, and Naturally Splendid to expand its market reach and product offerings. NeutriSci operates in the competitive nutraceuticals market, which includes a wide range of dietary supplements and functional foods. The company aims to differentiate itself through innovative product formulations and effective distribution strategies. However, the company's negative gross and profit margins indicate potential challenges in achieving profitability and sustainable growth.
Qué hacen
- Develops nutraceutical products.
- Markets nutraceutical products.
- Distributes nutraceutical products.
- Offers neuenergy, an energy tablet for focus and mental clarity.
- Sells products through retail channels.
- Sells products through online channels.
Modelo de Negocio
- Develops and manufactures nutraceutical products.
- Distributes products through retail and online channels.
- Generates revenue through product sales.
- Partners with other companies for distribution and product development.
Contexto de la Industria
NeutriSci International Inc. operates within the global nutraceuticals market, which is characterized by increasing consumer interest in health and wellness products. The market includes dietary supplements, functional foods, and beverages. Competition is intense, with numerous players ranging from large multinational corporations to smaller, specialized companies. NeutriSci's success depends on its ability to differentiate its products, establish strong distribution channels, and effectively market its offerings. The company faces competition from established brands and emerging players, requiring continuous innovation and adaptation to changing consumer preferences.
Clientes Clave
- Individuals seeking enhanced focus and mental clarity.
- Consumers interested in health and wellness products.
- Retailers selling nutraceutical products.
- Online consumers purchasing health supplements.
Finanzas
Gráfico e información
Precio de la acción de NeutriSci International Inc. (NRXCF): Price data unavailable
Últimas noticias
No hay noticias recientes disponibles para NRXCF.
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para NRXCF.
Objetivos de Precios
Análisis del precio objetivo de Wall Street para NRXCF.
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de NRXCF en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
Liderazgo: Glen Rehman
CEO
Glen Rehman serves as the CEO of NeutriSci International Inc. His background includes experience in the nutraceuticals and consumer packaged goods industries. He has held various leadership positions in sales, marketing, and operations, focusing on driving revenue growth and expanding market share. Rehman's expertise lies in developing and executing strategic plans, building strong teams, and fostering innovation. He is committed to delivering high-quality products and services to customers and creating value for shareholders.
Historial: Under Glen Rehman's leadership, NeutriSci International Inc. has focused on expanding its distribution network and developing new nutraceutical products. Key milestones include establishing partnerships with LaSanta Botanicals, Nutritional High, and Naturally Splendid. Rehman has also overseen the company's efforts to increase its online sales and brand awareness. However, the company's financial performance, particularly its negative gross and profit margins, remains a challenge.
Información del mercado OTC de NRXCF
The OTC Other tier represents the lowest tier of the OTC market, indicating that NeutriSci International Inc. may not meet the minimum financial or disclosure requirements for higher tiers like OTCQB or OTCQX. Companies on this tier often have limited trading volume and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries significant risks due to the lack of transparency and potential for fraud or manipulation. Investors should exercise extreme caution and conduct thorough due diligence before investing in these companies.
- Nivel OTC: OTC Other
- Estado de divulgación: Unknown
- Limited financial disclosure and transparency.
- Low trading volume and liquidity.
- Potential for price manipulation and fraud.
- Higher risk of delisting or going out of business.
- Lack of regulatory oversight compared to major exchanges.
- Verify the company's financial statements and audit reports.
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Review the company's legal and regulatory filings.
- Evaluate the company's capital structure and debt levels.
- Determine the company's ownership structure and insider holdings.
- Consult with a qualified financial advisor before investing.
- Company has been in operation since 2009.
- Partnerships with LaSanta Botanicals, Nutritional High, and Naturally Splendid.
- Distribution network in multiple countries.
- Development and marketing of neuenergy product.
Acciones de NeutriSci International Inc.: Preguntas Clave Respondidas
¿Cuáles son los factores clave para evaluar NRXCF?
NeutriSci International Inc. (NRXCF) actualmente tiene una puntuación IA de 56/100, indicando puntuación moderada. Fortaleza clave: Established distribution network in multiple countries.. Riesgo principal a monitorear: Ongoing: Intense competition in the nutraceuticals market from established brands and emerging players.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de NRXCF?
NRXCF actualmente puntúa 56/100 (Grado C) en el MoonshotScore, lo que sugiere calificación moderada. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de NRXCF?
Los precios de NRXCF se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre NRXCF?
La cobertura de analistas para NRXCF incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en NRXCF?
Las categorías de riesgo para NRXCF incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Ongoing: Intense competition in the nutraceuticals market from established brands and emerging players.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de NRXCF?
La relación P/E para NRXCF compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.
¿Está NRXCF sobrevalorada o infravalorada?
Determinar si NeutriSci International Inc. (NRXCF) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de NRXCF?
NeutriSci International Inc. (NRXCF) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- Financial data is limited due to the company's OTC listing.
- Analyst coverage is not available for this stock.
- Information is based on publicly available sources.